Short course treatment of pulmonary tuberculosis patients suffering from multiple drug resistance. The current situation and future perspectives

Short course treatment of pulmonary tuberculosis patients suffering from multiple drug resistance. The current situation and future perspectives

The article presents a review of 70 publications. It describes relevant data on drugs, timing, indications, efficacy, and safety of short-term treatment regimens for multiple drug resistant tuberculosis.

Bibliographic Details
Main Authors:	A. E. Russkikh, D. M. Kutuzova, O. V. Lovacheva, A. G. Samoylova, I. A. Vasilyeva
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2021-01-01
Series:	Туберкулез и болезни лёгких
Subjects:	краткосрочные схемы лечение туберкулеза туберкулез с множественной лекарственной устойчивостью бедаквилин моксифлоксацин клофазимин деламанид претоманид линезолид bpal-схема
Online Access:	https://www.tibl-journal.com/jour/article/view/1496

Similar Items

Comparative analysis of eﬃcacy and safety of various anti-tuberculosis therapy regimens in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2022-06-01)

Assessment of effectiveness of the empiric treatment regimen in tuberculosis patients suspected with multiple drug resistance in the Russian Federation
by: Sergey A. Sterlikov, et al.
Published: (2018-11-01)

Experience of using bedaquiline in the treatment of pulmonary tuberculosis patients with multiple drug resistance
by: T. I. Morozova, et al.
Published: (2016-02-01)

Treatment outcomes of multiple and extensive drug resistant tuberculosis and efficiency of surgical resections in patients with high risk of unfavorable outcomes
by: Ya. R. Batyrshina, et al.
Published: (2016-05-01)

EXPERIENCE OF USING BEDAQUILINE IN THE MULTIMODALITY THERAPY OF TUBERCULOSIS PATIENTS WITH CONCURRENT HIV INFECTION
by: G. S. BALASANYANTS
Published: (2017-10-01)

Multiple drug resistant tuberculosis in patients addicted to alcohol – a critical issue of the current tuberculosis control
by: I. S. Gelbert, et al.
Published: (2015-11-01)

ASSESSMENT OF CORRELATION BETWEEN HIV INFECTION AND TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE
by: Sergey A. Popov, et al.
Published: (2018-08-01)

Frequency of M. tuberculosis strains with different drug resistance profiles among pulmonary tuberculosis patients in the Kyrgyz Republic in 2016
by: A. A. Toktogonovа, et al.
Published: (2018-10-01)

Justification of Chemotherapy Duration in Patients with Multiple and Pre-Extensive Drug Resistant Tuberculosis in the Russian Federation
by: A. I. Gayda, et al.
Published: (2023-01-01)

Tuberculosis treatment outcomes in children
by: V. A. Аksenova, et al.
Published: (2021-11-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

FACTORS ASSOCIATED WITH ACQUIRED FLUOROQUINOLONE RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS IN THE NOVOSIBIRSK REGION
by: Ya. R. Batyrshina, et al.
Published: (2014-05-01)

Treatment outcomes of extensive drug resistant tuberculosis in the penitentiary system of the Russian Federation
by: S. A. Sterlikov, et al.
Published: (2018-11-01)

EXPERIENCE OF SHORT-COURSE TREATMENT IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: A. A. Toktogonovа, et al.
Published: (2018-06-01)

EFFICIENCY OF PULMONARY TUBERCULOSIS CHEMOTHERAPY IN NEW CASES DEPENDING ON THE TIME OFDRUG RESISTANCE DETECTION
by: M. V. Burаkovа, et al.
Published: (2017-12-01)

The Epidemiological Tuberculosis Situation in the Russian Penitentiary System: Main Trends and Challenges
by: V. V. Testov, et al.
Published: (2022-08-01)

Treatment of multiple drug resistant pulmonary tuberculosis in a diabetic patient with renal allograft
by: E. V. Korzh, et al.
Published: (2021-03-01)

EXPERIENCE OF TREATING MULTIPLE AND EXTENSIVE DRUG RESISTANT TUBERCULOSIS WITH NEW REGIMENS IN BELARUS REPUBLIC
by: E. M. Skryagina, et al.
Published: (2018-09-01)

THE NIDUS OF TUBERCULOUS INFECTION AS A RISK FACTOR OF MULTIPLE DRUG RESISTANT TUBERCULOSIS IN CHILDREN
by: V. A. Аksenovа, et al.
Published: (2018-01-01)

INDIVIDUAL TREATMENT OF PULMONARY MDR/XDR TUBERCULOSIS IN ADOLESCENTS
by: L. V. Pаnovа, et al.
Published: (2018-03-01)

Tuberculosis Cutis Orificialis of the Oral Cavity in a HIV Positive Patient with Pulmonary Tuberculosis
by: A. V. Kukurika, et al.
Published: (2022-08-01)

Specific tissue reactions after treatment with the valve bronchial block as per the data of pathomorphological examination of the resected material
by: S. V. Sklyuev, et al.
Published: (2015-11-01)

DIFFICULTIES IN MANAGING THE PATIENT WITH MULTIPLE DRUG RESISTANT TUBERCULOSIS AND CONCURRENT CONDITIONS
by: E. V. Vaniev, et al.
Published: (2016-07-01)

TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE USING NEW ANTI-TUBERCULOSIS DRUGS IN THE CIVILIAN COMMUNITY OF ARKHANGELSK REGION
by: Anastasiya I. Gayda, et al.
Published: (2018-08-01)

TUBERCULOSIS IN THE CORRECTIONAL FACILITIES OF RUSSIA IN 2012
by: I. M. Son, et al.
Published: (2014-07-01)

EVALUATION OF TREATMENT EFFICIENCY FOR MULTIPLE DRUG RESISTANT TUBERCULOSIS PATIENTS IN SIBERIAN AND FAR EASTERN FEDERAL DISTRICTS
by: O. P. Filippova, et al.
Published: (2015-09-01)

USE OF ENDOBRONCHIAL VALVES AND EXTRAPLEURAL SEALING FOR TREATMENT OF BILATERAL MASSIVE CAVITIES IN A FEMALE PATIENT WITH MULTIPLE DRUG RESISTANT PULMONARY TUBERCULOSIS
by: O. V. LOVАCHEVА, et al.
Published: (2017-10-01)

Pretomanid: Clinical Trials and Prospects to Be Used in Treatment Regimens for Multiple and Extensive Drug Resistant Tuberculosis
by: A. V. Kukurika
Published: (2021-07-01)

A clinical case of successful combined treatment of a patient with fibrous cavernous pulmonary tuberculosis and extensive drug resistance
by: P. N. Golubchikov, et al.
Published: (2020-07-01)

Medications for Short-Course Chemotherapy of Drug Resistant Tuberculosis and Their Effect on the Host
by: G. N. Mozhokina, et al.
Published: (2022-09-01)

Delamanid is a new anti-tuberculosis drug: use, limitations, and prospects
by: V. N. Zimina, et al.
Published: (2021-03-01)

CHARACTERISTICS AND EFFICIENCY OF TREATMENT IN TUBERCULOSIS PATIENTS DEPENDING ON THE ХPERT MTB/RIF RESULTS
by: A. M. MАLIK
Published: (2017-10-01)

DprE1 inhibitors – a prospective target for development of antituberculosis drugs
by: A. V. Kukurika
Published: (2022-06-01)

Preventive chemotherapy in children exposed to multiple drug resistant tuberculosis
by: V. A. Аksenova, et al.
Published: (2019-07-01)

Efficacy of treatment of extensive drug resistant tuberculosis in patients with different genotypes in the biotransformation enzyme genes of <i>CYP2B6</i> and <i>NAT2</i>
by: M. M. Yunusbаevа, et al.
Published: (2020-07-01)

A Clinical Case of Extensive Drug Resistant Pulmonary Tuberculosis Using an Endobronchial Valve. Analysis of Errors in the Choice of Chemotherapy Regimen
by: I. A. Burmistrovа, et al.
Published: (2021-11-01)

Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and in the world
by: S. A. Sterlikov, et al.
Published: (2016-01-01)

The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG
by: E. M. Zhukova, et al.
Published: (2019-12-01)

EXPERIENCE OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS PATIENTS WITH BEDAQUILINE IN AMUR REGION
by: L. Yu. Tikhonova, et al.
Published: (2018-07-01)

Perspectives of targeted chemotherapy with delamanid in the treatment regimens of those with multiple/extensive drug resistant tuberculosis. A success, chance or uncertainty?
by: Aleksey G. Naumov, et al.
Published: (2018-11-01)